ICFG Spain acted as Financial Adviser to Ava AG in its Series B financing round
Ava AG
Target | Ava AG |
Deal Type | Debt & Equity Financing |
Territory | Spain |
Transaction Description | Ava is a medical technology company focused on innovations in women’s reproductive health and maker of the popular cycle tracking Ava bracelet. Ava, being a digital diagnostics and therapeutics company has the vision to provide data-driven and scientifically proven insights along all stages of a woman’s reproductive life. “Ava’s long-term vision is to accompany women through all stages of their reproductive life by providing data-driven, clinically proven technology that will make a woman’s life easier, healthier and better — be it when they just want to understand their body, while they are trying to prevent pregnancy, trying to get pregnant, are pregnant or entering menopause,” Ava’s CEO Koenig explained. |
Industry Sector | Healthcare |
ICFG Office | Madrid |
Boltendahl International Partners organizes a private placement in the CHF 30m Series B Round for Ava AG. |